Herrera, C <br/><br/>
Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.  [electronic resource] 

 -  Bone marrow transplantation  Mar 1999 
 - 443-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1701493  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation--adverse effects<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Child<br/>Combined Modality Therapy<br/>Female<br/>Graft vs Host Disease--etiology<br/>Hematologic Neoplasms--immunology<br/>Histocompatibility Testing<br/>Humans<br/>Immunomagnetic Separation<br/>Immunosuppressive Agents--administration & dosage<br/>Lymphocyte Depletion<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Transplantation, Homologous<br/>Treatment Outcome